| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | postsynaptic specialization organization | 3.64e-05 | 71 | 19 | 3 | GO:0099084 | |
| GeneOntologyBiologicalProcess | atrial septum morphogenesis | 1.22e-04 | 18 | 19 | 2 | GO:0060413 | |
| GeneOntologyBiologicalProcess | pulmonary valve morphogenesis | 1.51e-04 | 20 | 19 | 2 | GO:0003184 | |
| GeneOntologyBiologicalProcess | pulmonary valve development | 2.19e-04 | 24 | 19 | 2 | GO:0003177 | |
| GeneOntologyBiologicalProcess | atrial septum development | 2.38e-04 | 25 | 19 | 2 | GO:0003283 | |
| Domain | ANK_REPEAT | 2.03e-03 | 253 | 19 | 3 | PS50088 | |
| Domain | ANK_REP_REGION | 2.05e-03 | 254 | 19 | 3 | PS50297 | |
| Domain | ASX_HYDROXYL | 4.57e-03 | 100 | 19 | 2 | PS00010 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 5.12e-03 | 106 | 19 | 2 | IPR000152 | |
| Domain | EGF | 7.16e-03 | 126 | 19 | 2 | PF00008 | |
| Domain | Growth_fac_rcpt_ | 1.08e-02 | 156 | 19 | 2 | IPR009030 | |
| Domain | Ank_2 | 1.98e-02 | 215 | 19 | 2 | PF12796 | |
| Domain | Ank | 2.21e-02 | 228 | 19 | 2 | PF00023 | |
| Pathway | KEGG_DORSO_VENTRAL_AXIS_FORMATION | 1.81e-04 | 24 | 12 | 2 | M11190 | |
| Pathway | WP_PRIMARY_OVARIAN_INSUFFICIENCY | 3.75e-04 | 174 | 12 | 3 | M48058 | |
| Pathway | WP_15Q25_COPY_NUMBER_VARIATION | 6.73e-04 | 46 | 12 | 2 | M48105 | |
| Pathway | WP_CARDIAC_PROGENITOR_DIFFERENTIATION | 8.94e-04 | 53 | 12 | 2 | M39681 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 1.47e-03 | 68 | 12 | 2 | M27303 | |
| Pubmed | Ripply2 is essential for precise somite formation during mouse early development. | 2.82e-06 | 5 | 19 | 2 | 17531978 | |
| Pubmed | Mesp2 initiates somite segmentation through the Notch signalling pathway. | 7.90e-06 | 8 | 19 | 2 | 10932180 | |
| Pubmed | 1.02e-05 | 9 | 19 | 2 | 9707552 | ||
| Pubmed | Dynamic expression and essential functions of Hes7 in somite segmentation. | 1.55e-05 | 11 | 19 | 2 | 11641270 | |
| Pubmed | 1.55e-05 | 11 | 19 | 2 | 9242490 | ||
| Pubmed | The bHLH regulator pMesogenin1 is required for maturation and segmentation of paraxial mesoderm. | 1.86e-05 | 12 | 19 | 2 | 11124811 | |
| Pubmed | 1.86e-05 | 12 | 19 | 2 | 17572911 | ||
| Pubmed | 2.20e-05 | 13 | 19 | 2 | 11262239 | ||
| Pubmed | Genetic rescue of segmentation defect in MesP2-deficient mice by MesP1 gene replacement. | 2.56e-05 | 14 | 19 | 2 | 9739106 | |
| Pubmed | 3.83e-05 | 17 | 19 | 2 | 15155583 | ||
| Pubmed | Mutations in the NOTCH pathway regulator MIB1 cause left ventricular noncompaction cardiomyopathy. | 5.34e-05 | 20 | 19 | 2 | 23314057 | |
| Pubmed | 7.75e-05 | 24 | 19 | 2 | 21633169 | ||
| Pubmed | Wnt5a and Wnt11 regulate mammalian anterior-posterior axis elongation. | 1.66e-04 | 35 | 19 | 2 | 25813538 | |
| Pubmed | 2.69e-04 | 1116 | 19 | 5 | 31753913 | ||
| Pubmed | Global discovery of erythroid long noncoding RNAs reveals novel regulators of red cell maturation. | 4.13e-04 | 55 | 19 | 2 | 24200680 | |
| Pubmed | Common genetic variation and performance on standardized cognitive tests. | 5.24e-04 | 62 | 19 | 2 | 20125193 | |
| Pubmed | Analysis of BCL6-interacting proteins by tandem mass spectrometry. | 5.24e-04 | 62 | 19 | 2 | 16147992 | |
| Cytoband | 15q25.2 | 1.45e-04 | 43 | 19 | 2 | 15q25.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr15q25 | 1.99e-03 | 160 | 19 | 2 | chr15q25 | |
| GeneFamily | Ankyrin repeat domain containing | 7.48e-03 | 242 | 10 | 2 | 403 | |
| Coexpression | DESCARTES_FETAL_SPLEEN_MESOTHELIAL_CELLS | 2.25e-07 | 194 | 19 | 5 | M40292 | |
| Coexpression | KOINUMA_TARGETS_OF_SMAD2_OR_SMAD3 | 1.25e-06 | 843 | 19 | 7 | M2356 | |
| Coexpression | CUI_DEVELOPING_HEART_C6_EPICARDIAL_CELL | 1.05e-05 | 195 | 19 | 4 | M39303 | |
| Coexpression | KRAS.PROSTATE_UP.V1_DN | 1.39e-04 | 141 | 19 | 3 | M2901 | |
| ToppCell | COVID-19-lung-Mesothelial|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.32e-07 | 164 | 19 | 4 | 83303e2ba52008391b8dc3fae8225ab5bcb20063 | |
| ToppCell | P15-Mesenchymal-mesenchymal_fibroblast-mesothelial_cell_of_visceral_pleura|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.63e-07 | 166 | 19 | 4 | 545f6c91102568791443717e522f89cb3bd1a070 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.76e-07 | 178 | 19 | 4 | 1bddbc083c36657bd6910f7466126ab325e88176 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.76e-07 | 178 | 19 | 4 | a74e5a390cbeaca9de1fdb7b2a0e50783bd202dd | |
| ToppCell | P28-Mesenchymal-mesenchymal_fibroblast-mesothelial_cell_of_visceral_pleura|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 8.76e-07 | 178 | 19 | 4 | 1e05bc26591fea16e29bcfc5f538dda1dc427f05 | |
| ToppCell | LA-05._Cytoplasmic_Cardiomyocyte_I|World / Chamber and Cluster_Paper | 1.16e-06 | 191 | 19 | 4 | d825e55278dce666c332cc060d1255659e07e568 | |
| ToppCell | COVID-19-lung-Mesothelial|lung / Disease (COVID-19 only), tissue and cell type | 3.80e-05 | 156 | 19 | 3 | e1f563869b3bf997eaa2e756e31b53db1a478903 | |
| ToppCell | TCGA-Testes-Primary_Tumor-Testicular_Germ_Cell_Tumor-Seminoma-_NOS|TCGA-Testes / Sample_Type by Project: Shred V9 | 4.33e-05 | 163 | 19 | 3 | 67551fefe22bd5b8178fa248fed2a6c17b19fb0f | |
| ToppCell | TCGA-Testes-Primary_Tumor-Testicular_Germ_Cell_Tumor-Seminoma-_NOS-5|TCGA-Testes / Sample_Type by Project: Shred V9 | 4.33e-05 | 163 | 19 | 3 | 80bc3732afd8501938753120b8403098c7c5e928 | |
| ToppCell | Control-Epithelial-Mesothelial|Control / Disease state, Lineage and Cell class | 4.58e-05 | 166 | 19 | 3 | 1ed3788257e14f097862b999f020bfe2a57de52b | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.66e-05 | 167 | 19 | 3 | 351f8de1fbdf742ac74f9099b254d515ab539bb2 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.66e-05 | 167 | 19 | 3 | c042d6cdddd0e1ddef1e3ac6f4fe23151127b0f2 | |
| ToppCell | normal_Lung-Fibroblasts-Mesothelial_cells|Fibroblasts / Location, Cell class and cell subclass | 4.66e-05 | 167 | 19 | 3 | 892a2dc83ab5de5a1016402f8e95d2aabf651326 | |
| ToppCell | control-Myeloid-pDC|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.74e-05 | 168 | 19 | 3 | affc39c7568b7df4b36af6f5b0e3702a18b6268c | |
| ToppCell | 368C-Fibroblasts-Fibroblast-J_(Lipofibroblast)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 4.74e-05 | 168 | 19 | 3 | 403aba73a0f9ffb32252288d075fad8a588ca440 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-J_(Lipofibroblast)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 4.74e-05 | 168 | 19 | 3 | e870d2e69316406f45112ed0bf324b24f902a99e | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2-CAP2_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.83e-05 | 169 | 19 | 3 | 8a6d05b5d60b2b2e43a8ff7521feb79cd6dbd940 | |
| ToppCell | 15-Airway-Epithelial-Club-like_secretory|Airway / Age, Tissue, Lineage and Cell class | 4.91e-05 | 170 | 19 | 3 | 1418031cc4b4a87a48621eb53a3c819cd713ddd0 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.17e-05 | 173 | 19 | 3 | 30d67738633493d47f06ae452424382f069b6c0a | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.26e-05 | 174 | 19 | 3 | a9c6edf5c3fc119c24425f921c5566a8356c30fe | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.45e-05 | 176 | 19 | 3 | 8e7f38de8bf68077e2138f4d06c1f55b0fd096cc | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.45e-05 | 176 | 19 | 3 | ed575330a08a6748ea4b28433292c8cfd157d444 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_1-Mesothelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.54e-05 | 177 | 19 | 3 | 0912a291cff32a4ff8a2d7680ed1a1cd867fb90f | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.73e-05 | 179 | 19 | 3 | 815b959ce8721c5ded70c0ca6e318dafc691746e | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.73e-05 | 179 | 19 | 3 | a3922476f33d2e4137a12dbda21a1703dff79684 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-mesothelial_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.92e-05 | 181 | 19 | 3 | 65eaa9bc1022bcf0c5f0f92c07a2cbbf11f9b59c | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1_FGFR3_MT1G|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.92e-05 | 181 | 19 | 3 | 0c3f469bed108994ed696230e3c30343f7a301d3 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-mesothelial_cell-Mesothelium_(PRG4+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.92e-05 | 181 | 19 | 3 | eaac7d58117eddfff06b25521efc431c1351d592 | |
| ToppCell | IPF-Epithelial-Mesothelial|World / Disease state, Lineage and Cell class | 6.11e-05 | 183 | 19 | 3 | 7df20e3172a1220ff427f30181f4f0c3b7fe2d42 | |
| ToppCell | droplet-Heart-4Chambers-18m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.11e-05 | 183 | 19 | 3 | 6c4a09c02e30e1f24dde39f8cb8c5b453826ee2e | |
| ToppCell | E17.5-Mesenchymal-mesenchymal_fibroblast-mesothelial_cell_of_visceral_pleura|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.21e-05 | 184 | 19 | 3 | 607b55022de21ddb6a2d75e085df76df7abf6624 | |
| ToppCell | COPD-Epithelial-Mesothelial|World / Disease state, Lineage and Cell class | 6.31e-05 | 185 | 19 | 3 | 23579988036fc1925992c31919750f9b3fe9f790 | |
| ToppCell | pdx|World / Sample and Cell Type and Tumor Cluster (all cells) | 6.42e-05 | 186 | 19 | 3 | de8e538c8767d41b8a52f5e58ba1affd4e7244c4 | |
| ToppCell | pdx-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 6.42e-05 | 186 | 19 | 3 | 0b88a87158a9ca8de3bf40a4ff1687150707a5f0 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1-6_FGFR3_ETNPPL|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.52e-05 | 187 | 19 | 3 | 4d2115a05ec36dd179ca1d4a525f2d4501aea557 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.52e-05 | 187 | 19 | 3 | 9d77ca45f7563bd6f2a0c1be5d99d93ad30983f7 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Astro|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.52e-05 | 187 | 19 | 3 | ae90c263f80c36a410150d499e268d198944a3d9 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Astro-Astrocyte|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.52e-05 | 187 | 19 | 3 | dd1d91f101b837bba513f77defa6e6902b2c0570 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D175|Adult / Lineage, Cell type, age group and donor | 6.62e-05 | 188 | 19 | 3 | ec38def1fdbb34ed9b30244806975bd5a4370164 | |
| ToppCell | COPD-Epithelial-Mesothelial|COPD / Disease state, Lineage and Cell class | 6.73e-05 | 189 | 19 | 3 | 79bb2593ad5d17f94b17972884241f03a0f43770 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 6.83e-05 | 190 | 19 | 3 | 625c08a0e5227efc46daa512fd579c3938ff76c7 | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1-6_FGFR3_ETNPPL|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.83e-05 | 190 | 19 | 3 | 5c64b727669b23d2a23c8ad1d5d6caab7af37d56 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Astro|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.83e-05 | 190 | 19 | 3 | 3a55cc5dc2549788bfe55f649686887b21a1fdd2 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.83e-05 | 190 | 19 | 3 | 2de8e4cfeee350a9a76af749d6ce58d948c129b8 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Astro-Astrocyte|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.83e-05 | 190 | 19 | 3 | 1c3d601422efa60fad8565f9ccd9032b847e4a91 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_mesothelial_(19)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 6.94e-05 | 191 | 19 | 3 | 4c4eb61e6179d2f8fc524d2f813db9cba84f67a2 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.94e-05 | 191 | 19 | 3 | f3158cedf67e3b90aa94ea1f61c72c33aaa2d5ba | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Astro-Astrocyte|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.05e-05 | 192 | 19 | 3 | f7e4509003d71f805b9d4587098e90d2897b6739 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1-6_FGFR3_ETNPPL|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.05e-05 | 192 | 19 | 3 | 43beaac1de99b9c1a6dab4a450b4e81286987b64 | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Astro|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.05e-05 | 192 | 19 | 3 | 705ce805cb00a53793b57bcf466d0fbec590a83c | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Astro|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.16e-05 | 193 | 19 | 3 | 40edc07b6e7f19f6ee885fa5af0b63ef1b0f2468 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Astro-Astrocyte|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.16e-05 | 193 | 19 | 3 | b03d908d4b8940927f72c76a1b0f237d13f39056 | |
| ToppCell | Bronchial-NucSeq-Stromal-Mesofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.49e-05 | 196 | 19 | 3 | 96e5c6d155273e82ebafa180df8bb589c3e3e54e | |
| ToppCell | Bronchial-NucSeq-Stromal-Mesofibroblastic-Mesothelia|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.49e-05 | 196 | 19 | 3 | ce13af36fc2932e8125013041742593ff3d07e86 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Mesofibroblastic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.61e-05 | 197 | 19 | 3 | 88a86286b9c3ea3b076d7464faec42d0392ee7f8 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Mesofibroblastic-Mesothelia|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.61e-05 | 197 | 19 | 3 | 2773d2eb5f232a7e49da116efffcb6bf5eb90810 | |
| ToppCell | Biopsy_Other_PF-Mesenchymal-Mesothelial_cells|Biopsy_Other_PF / Sample group, Lineage and Cell type | 7.72e-05 | 198 | 19 | 3 | 86736f01e61bf4961f060b24ee1f1f48340737dd | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW23-Neuronal-Cortical_neuron|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 7.96e-05 | 200 | 19 | 3 | 7bba2ff09349c8db3d1ccf53520b12cbf7b0abac | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_1-Differentiating_AT2|Control_saline / Treatment groups by lineage, cell group, cell type | 7.96e-05 | 200 | 19 | 3 | eac33be484dc443794e66e473f03e98406c2983e | |
| ToppCell | Cerebellum-Macroglia-ASTROCYTE-Gja1-Gfap-_astrocytes_(Htra1)|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 3.90e-04 | 69 | 19 | 2 | c93a47ee777b560f69b705d5d597f3cb3a3f558a | |
| ToppCell | Cerebellum-Macroglia-ASTROCYTE-Gja1-Gfap-_astrocytes_(Htra1)-|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 3.90e-04 | 69 | 19 | 2 | 54e5ede00ce2920158d1cc0ac8e718aa24a4342e | |
| ToppCell | Cerebellum-Macroglia-ASTROCYTE-Gja1-Gfap-_astrocytes_(Htra1)--|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 3.90e-04 | 69 | 19 | 2 | 8946d7e433c232c56563a6c464152c0a8cdbdf92 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.84e-04 | 98 | 19 | 2 | ffe21b3681fdeaf4a8447bd2b13772d03cdd45aa | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-Mes-Like|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.65e-04 | 103 | 19 | 2 | c11bb0238e81a42dad5d7687c9d22474129d803d | |
| ToppCell | TCGA-Kidney-Primary_Tumor-Renal_Cell_Carcinoma-Kidney_Clear_Cell_Renal_Carcinoma-8|TCGA-Kidney / Sample_Type by Project: Shred V9 | 1.23e-03 | 123 | 19 | 2 | 967f20fcb27c9989de93f4183038334105910175 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.31e-03 | 127 | 19 | 2 | 5b0adbcafad31a6759c9bdce2f7f9591a8edc450 | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_NOS-7|TCGA-Stomach / Sample_Type by Project: Shred V9 | 1.31e-03 | 127 | 19 | 2 | 5e4d110cc6e68cd8fc7a4771a65e6f8cd83e7721 | |
| ToppCell | E16.5-samps-Mesenchymal-Myofibroblast-myofibroblast_-_immature|E16.5-samps / Age Group, Lineage, Cell class and subclass | 1.35e-03 | 129 | 19 | 2 | 5e4783cc63afdeaebdfaecb72f95f3efc8d3c4a3 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.37e-03 | 130 | 19 | 2 | 6434d9106ccb38786dad36fab80163dfc07b6eb7 | |
| ToppCell | NS-moderate-d_07-13-Epithelial-unknown_epithelial|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.37e-03 | 130 | 19 | 2 | 1491e8975520e99c527a5b5bee64875d124f7bf4 | |
| ToppCell | E18.5-samps-Mesenchymal-Matrix_fibroblast-matrix_-_mature_2|E18.5-samps / Age Group, Lineage, Cell class and subclass | 1.39e-03 | 131 | 19 | 2 | f2eee150f5cff852e8f52f09b35e26f17d80833b | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.44e-03 | 133 | 19 | 2 | 5bf5e654653e2c340891f51e3f2a30441b7b6b2b | |
| ToppCell | TCGA-Adrenal-Primary_Tumor-Pheochromocytoma-Pheochromocytoma-5|TCGA-Adrenal / Sample_Type by Project: Shred V9 | 1.46e-03 | 134 | 19 | 2 | d4b175257c47916ed90cdb5c555c2b26530ce8d5 | |
| ToppCell | E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal-Intermediate_Fibroblast|E16.5-samps / Age Group, Lineage, Cell class and subclass | 1.52e-03 | 137 | 19 | 2 | dd5364a1002650d21e0c83d8c701b5f7b09d1c19 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(EC)|kidney / Disease (COVID-19 only), tissue and cell type | 1.57e-03 | 139 | 19 | 2 | 64c35411bbe67acb5010dadc4b0b1be0f8b17737 | |
| ToppCell | TCGA-Bladder-Solid_Tissue_Normal-Urothelial_normal_tissue-Urothelial_normal_tissue-2|TCGA-Bladder / Sample_Type by Project: Shred V9 | 1.61e-03 | 141 | 19 | 2 | 1baa054c2ae3b446d1954244b7fbf8af824ef345 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Connecting_Tubule_Intercalated_Cell_Type_A|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.70e-03 | 145 | 19 | 2 | 9964d6d3769be2f35d86268fe044cecd1d5a1616 | |
| ToppCell | E18.5-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_A|E18.5-samps / Age Group, Lineage, Cell class and subclass | 1.77e-03 | 148 | 19 | 2 | 5729826e8d45bf995e2efa6707c49e264d12d112 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-03 | 148 | 19 | 2 | ba277c898678dd36f8dc1d681301c71901b89055 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-03 | 148 | 19 | 2 | b4632029ebd14969bda59a1bd1454eadb8efe563 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Neuronal-Cortical_neuron|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 1.77e-03 | 148 | 19 | 2 | a1269312903fc27830c1835dabf660c659a711be | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-AT2_Progenitor|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.89e-03 | 153 | 19 | 2 | e7a074ea8232bacf924be78a244a8507c7e1ebc8 | |
| ToppCell | PBMC-Control-cDC_2|Control / Compartment, Disease Groups and Clusters | 1.89e-03 | 153 | 19 | 2 | 4ee37266b0054f276c7a73ab9220f681b9d74c71 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_PP_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.92e-03 | 154 | 19 | 2 | 2d98bb7a784fc3215e0d4a1670d662e5df4716c3 | |
| ToppCell | PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD8_T-CD8_T_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.92e-03 | 154 | 19 | 2 | f78b01c19afcbab6319f61e4d6023ecb3d510d24 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_PP_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.92e-03 | 154 | 19 | 2 | 0dec222101530f1727184dbb7c03969d3884f111 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.92e-03 | 154 | 19 | 2 | 66c93733116e31b65dfb4b0b00de5c39d19cdb84 | |
| ToppCell | P28-Epithelial-epithelial_progenitor_cell-epi_progenitor|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.94e-03 | 155 | 19 | 2 | be575a0096415705dba425002247289ff8f89474 | |
| ToppCell | 3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.94e-03 | 155 | 19 | 2 | 62b59cb32b12bd55b19e98786a866d788fc9e4bf | |
| ToppCell | PND07-28-samps-Mesenchymal-Mesothelial-Mesothelial|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 1.97e-03 | 156 | 19 | 2 | 605d95a900e1443d3f6aae163ef2e893d3293203 | |
| ToppCell | 10x5'-Lung-Lymphocytic_T_CD4-T_CD4/CD8|Lung / Manually curated celltypes from each tissue | 1.97e-03 | 156 | 19 | 2 | 10d191e29b16cae8238e8df6c0ff38882253f34e | |
| ToppCell | 10x5'-Lung-Lymphocytic_T_CD4/8-lo-Tgd_CRTAM|Lung / Manually curated celltypes from each tissue | 1.97e-03 | 156 | 19 | 2 | 0ea6ca3f38109151a2a4fdf63a4f009929cdcc40 | |
| ToppCell | PND07-28-samps-Mesenchymal-Mesothelial|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 1.97e-03 | 156 | 19 | 2 | 574f761962a7dd3308bd41fc529dd3ea1b8625f8 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.99e-03 | 157 | 19 | 2 | c17c5c01fcb65c453690c265ec4f300ecdfefd34 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.04e-03 | 159 | 19 | 2 | 8680b054622f573a82b1625fb93c2d5db81d1034 | |
| ToppCell | IIF-Lymphocyte-T_NK-ILC|IIF / Disease, Lineage and Cell Type | 2.04e-03 | 159 | 19 | 2 | 55e4f21548f480ca414c00cbff5ec3b13bafd271 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.09e-03 | 161 | 19 | 2 | 2d63b279d9a5132e1c09b03930bf9039036d24a2 | |
| ToppCell | 10x5'-Lung-Lymphocytic_T_CD4/8-lo|Lung / Manually curated celltypes from each tissue | 2.09e-03 | 161 | 19 | 2 | a1f10e04836848b1deaf295fae033f54d1572fcd | |
| ToppCell | droplet-Heart-4Chambers|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.12e-03 | 162 | 19 | 2 | 5625ec6dae204d5537883f05ea546970628d10bb | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Basal/Suprabasal-Suprabasal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.12e-03 | 162 | 19 | 2 | 112fa4de685727f6c8bf6fc4afb82de0524070ad | |
| Drug | Methantheline bromide [53-46-3]; Down 200; 9.6uM; HL60; HT_HG-U133A | 1.94e-05 | 198 | 19 | 4 | 6137_DN | |
| Drug | Cisapride [81098-60-4]; Up 200; 8.6uM; HL60; HT_HG-U133A | 1.98e-05 | 199 | 19 | 4 | 2443_UP | |
| Drug | Etodolac [41340-25-4]; Up 200; 14uM; PC3; HT_HG-U133A | 1.98e-05 | 199 | 19 | 4 | 7246_UP | |
| Drug | Cycloheximide [66-81-9]; Down 200; 14.2uM; HL60; HT_HG-U133A | 3.69e-04 | 171 | 19 | 3 | 2723_DN | |
| Drug | indeno(1,2,3-cd)pyrene | 3.82e-04 | 173 | 19 | 3 | ctd:C041508 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 4.43e-04 | 182 | 19 | 3 | 5802_DN | |
| Drug | Pyrvinium pamoate [3546-41-6]; Down 200; 3.4uM; MCF7; HT_HG-U133A | 4.65e-04 | 185 | 19 | 3 | 5439_DN | |
| Drug | 17-AAG; Up 200; 1uM; PC3; HT_HG-U133A | 4.95e-04 | 189 | 19 | 3 | 4450_UP | |
| Drug | Risperidone [106266-06-2]; Down 200; 9.8uM; HL60; HT_HG-U133A | 5.18e-04 | 192 | 19 | 3 | 2947_DN | |
| Drug | Pramoxine hydrochloride [637-58-1]; Up 200; 12.2uM; PC3; HT_HG-U133A | 5.26e-04 | 193 | 19 | 3 | 3811_UP | |
| Drug | Etifenin [63245-28-3]; Down 200; 12.4uM; HL60; HT_HG-U133A | 5.26e-04 | 193 | 19 | 3 | 2477_DN | |
| Drug | Sulfameter [651-06-9]; Down 200; 14.2uM; PC3; HT_HG-U133A | 5.34e-04 | 194 | 19 | 3 | 5732_DN | |
| Drug | Cephalothin sodium salt [58-71-9]; Down 200; 9.6uM; HL60; HT_HG-U133A | 5.42e-04 | 195 | 19 | 3 | 2517_DN | |
| Drug | Talampicillin hydrochloride [39878-70-1]; Up 200; 7.8uM; PC3; HT_HG-U133A | 5.42e-04 | 195 | 19 | 3 | 7254_UP | |
| Drug | Asiaticoside [16830-15-2]; Down 200; 4.2uM; MCF7; HT_HG-U133A | 5.42e-04 | 195 | 19 | 3 | 3504_DN | |
| Drug | STOCK1N-28457; Down 200; 20uM; MCF7; HT_HG-U133A | 5.42e-04 | 195 | 19 | 3 | 6906_DN | |
| Drug | Coralyne chloride hydrate [38989-38-7]; Up 200; 9.6uM; HL60; HT_HG-U133A | 5.42e-04 | 195 | 19 | 3 | 1298_UP | |
| Drug | Nitrarine dihydrochloride [20069-05-0]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 5.42e-04 | 195 | 19 | 3 | 4705_UP | |
| Drug | Scopoletin [92-61-5]; Down 200; 20.8uM; MCF7; HT_HG-U133A | 5.42e-04 | 195 | 19 | 3 | 6510_DN | |
| Drug | Prazosin hydrochloride [19237-84-4]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 5.42e-04 | 195 | 19 | 3 | 5416_DN | |
| Drug | haloperidol; Down 200; 10uM; HL60; HT_HG-U133A | 5.42e-04 | 195 | 19 | 3 | 1144_DN | |
| Drug | Disopyramide [3737-09-5]; Up 200; 11.8uM; PC3; HT_HG-U133A | 5.50e-04 | 196 | 19 | 3 | 7276_UP | |
| Drug | Aceclofenac [89796-99-6]; Up 200; 11.2uM; PC3; HT_HG-U133A | 5.50e-04 | 196 | 19 | 3 | 7269_UP | |
| Drug | Phenelzine sulfate [156-51-4]; Down 200; 17uM; PC3; HT_HG-U133A | 5.50e-04 | 196 | 19 | 3 | 4538_DN | |
| Drug | Fenbendazole [43210-67-9]; Down 200; 13.4uM; HL60; HT_HG-U133A | 5.50e-04 | 196 | 19 | 3 | 2360_DN | |
| Drug | Dicloxacillin sodium salt [13412-64-1]; Down 200; 8.2uM; PC3; HT_HG-U133A | 5.50e-04 | 196 | 19 | 3 | 6666_DN | |
| Drug | Condelphine [7633-69-4]; Down 200; 8.8uM; PC3; HT_HG-U133A | 5.50e-04 | 196 | 19 | 3 | 6357_DN | |
| Drug | Naphazoline hydrochloride [550-99-2]; Up 200; 16.2uM; PC3; HG-U133A | 5.50e-04 | 196 | 19 | 3 | 1886_UP | |
| Drug | clozapine; Down 200; 10uM; HL60; HT_HG-U133A | 5.58e-04 | 197 | 19 | 3 | 2689_DN | |
| Drug | Triamterene [396-01-0]; Down 200; 15.8uM; MCF7; HT_HG-U133A | 5.58e-04 | 197 | 19 | 3 | 1697_DN | |
| Drug | ICI182,780; Down 200; 1uM; PC3; HT_HG-U133A | 5.58e-04 | 197 | 19 | 3 | 6867_DN | |
| Drug | Demeclocycline hydrochloride [64-73-3]; Down 200; 8uM; MCF7; HT_HG-U133A | 5.58e-04 | 197 | 19 | 3 | 3404_DN | |
| Drug | Phenindione [83-12-5]; Up 200; 18uM; PC3; HT_HG-U133A | 5.58e-04 | 197 | 19 | 3 | 7289_UP | |
| Drug | Aminocaproic acid [60-32-2]; Up 200; 30.4uM; PC3; HT_HG-U133A | 5.58e-04 | 197 | 19 | 3 | 7258_UP | |
| Drug | Thiamphenicol [15318-45-3]; Up 200; 11.2uM; PC3; HT_HG-U133A | 5.58e-04 | 197 | 19 | 3 | 7274_UP | |
| Drug | Alfadolone acetate [23930-37-2]; Up 200; 10.2uM; PC3; HT_HG-U133A | 5.58e-04 | 197 | 19 | 3 | 7262_UP | |
| Drug | Merbromin [129-16-8]; Down 200; 5uM; MCF7; HT_HG-U133A | 5.58e-04 | 197 | 19 | 3 | 3439_DN | |
| Drug | SR-95639A [115767-94-7]; Up 200; 10uM; MCF7; HT_HG-U133A | 5.66e-04 | 198 | 19 | 3 | 4977_UP | |
| Drug | Naftifine hydrochloride [65473-14-5]; Up 200; 12.4uM; PC3; HT_HG-U133A | 5.66e-04 | 198 | 19 | 3 | 7273_UP | |
| Drug | Dexamethasone acetate [1177-87-3]; Down 200; 9.2uM; MCF7; HT_HG-U133A | 5.66e-04 | 198 | 19 | 3 | 6271_DN | |
| Drug | Gabazine [105538-73-6]; Down 200; 10.8uM; HL60; HT_HG-U133A | 5.66e-04 | 198 | 19 | 3 | 1316_DN | |
| Drug | Oxolinic acid [14698-29-4]; Down 200; 15.4uM; PC3; HT_HG-U133A | 5.66e-04 | 198 | 19 | 3 | 5094_DN | |
| Drug | SC-560; Down 200; 10uM; PC3; HT_HG-U133A | 5.66e-04 | 198 | 19 | 3 | 6865_DN | |
| Drug | Citalopram hydrobromide [59729-32-7]; Down 200; 1uM; PC3; HT_HG-U133A | 5.75e-04 | 199 | 19 | 3 | 4555_DN | |
| Drug | Glycocholic acid [475-31-0]; Up 200; 8.6uM; HL60; HT_HG-U133A | 5.75e-04 | 199 | 19 | 3 | 2454_UP | |
| Drug | Lymecycline [992-21-2]; Up 200; 6.6uM; HL60; HT_HG-U133A | 5.75e-04 | 199 | 19 | 3 | 2953_UP | |
| Drug | Repaglinide [135062-02-1]; Down 200; 8.8uM; PC3; HT_HG-U133A | 5.83e-04 | 200 | 19 | 3 | 5862_DN | |
| Disease | nucleus accumbens volume change measurement | 2.15e-05 | 11 | 19 | 2 | EFO_0021493 | |
| Disease | coronary aneurysm | 2.31e-04 | 35 | 19 | 2 | EFO_1000881 | |
| Disease | Tourette syndrome | 4.72e-04 | 50 | 19 | 2 | EFO_0004895 | |
| Disease | Alcoholic Intoxication, Chronic | 6.45e-04 | 268 | 19 | 3 | C0001973 | |
| Disease | daytime rest measurement | 8.51e-04 | 295 | 19 | 3 | EFO_0007828 | |
| Disease | attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement | 1.51e-03 | 801 | 19 | 4 | EFO_0003888, EFO_0007052, MONDO_0002491 | |
| Disease | sodium measurement | 1.99e-03 | 103 | 19 | 2 | EFO_0009282 | |
| Disease | Glioblastoma Multiforme | 2.30e-03 | 111 | 19 | 2 | C1621958 | |
| Disease | blood nickel measurement | 2.68e-03 | 120 | 19 | 2 | EFO_0007583 | |
| Disease | tea consumption measurement | 3.09e-03 | 129 | 19 | 2 | EFO_0010091 | |
| Disease | bipolar disorder | 5.71e-03 | 577 | 19 | 3 | MONDO_0004985 | |
| Disease | smoking status measurement | 5.74e-03 | 1160 | 19 | 4 | EFO_0006527 | |
| Disease | health study participation | 6.90e-03 | 195 | 19 | 2 | EFO_0010130 | |
| Disease | uterine fibroid | 7.18e-03 | 199 | 19 | 2 | EFO_0000731 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TSSMKSESSSHSSWD | 861 | Q01954 | |
| SESSSHSSWDSDGVS | 866 | Q01954 | |
| SSDETSSDSLKSWHS | 11 | Q96M86 | |
| SDHQRAWSSTDSDSS | 356 | Q9UBL0 | |
| DDWTTATVSSTSSSD | 71 | Q2T9L4 | |
| SSTSKASSWTSESTA | 511 | Q8WXI7 | |
| SSSSPHSASDWSDVT | 2426 | Q04721 | |
| ASSISASDLSSTHWT | 791 | Q9P2G4 | |
| TDRGSHSDLWSSSSS | 251 | Q8IX03 | |
| HSDLWSSSSSLESSS | 256 | Q8IX03 | |
| GHWDSTSPASSSDSS | 26 | Q0VG99 | |
| ESSSSSTSSTSDAFW | 231 | Q8IXQ8 | |
| WTSTESLSSSNSDDN | 86 | Q14678 | |
| WSTQDSDSSAQSSTH | 111 | Q9BZB8 | |
| WARASSSLSSSSSSS | 1261 | Q9NZM4 | |
| SDHSRSNKSSWSSSD | 1141 | Q9ULU4 | |
| SSVWSSSNVASSSST | 31 | Q9HDB5 | |
| SSSSSSSSSSSAAWA | 166 | O15197 | |
| LSATSSSESSWHQAS | 1061 | Q92540 | |
| LTSESSWTTHSEDTS | 146 | Q8WXE9 | |
| SDNLSLSSWVSSSSS | 341 | Q9UMR3 | |
| SSSSDTWSHSQSSDT | 351 | Q9P206 |